. .

 
Zuruecksetzen

Suchergebnis - VERTEX PHARMACEUTICALS INC. REGISTERED SHARES DL -,01

Zeit Titel
26.09 15:22dpa-AFX: Vertex Says Health Canada Accepts NDS For Triple Combination To Treat Cystic Fibrosis
26.09 15:02dpa-AFX: *VERTEX ANNOUNCES HEALTH CANADA ACCEPTANCE OF NEW DRUG SUBMISSION FOR NEXT-GEN CYSTIC FIBROSIS TREATMENT
26.09 04:41dpa-AFX: Health Canada Oks Vertex's CASGEVY, First CRISPR/Cas9 Gene-Edited Therapy For Sickle Cell Disease
04.08 11:00dpa-AFX: Weekly Biotech Buzz: FGEN Cuts Jobs, FDA OKs ADAP's Groundbreaking Cell Therapy, ME Rebuffs CEO Bid
02.08 00:07dpa-AFX: Vertex Pharmaceuticals Inc. Q2 Earnings Summary
01.08 23:51dpa-AFX: *VERTEX Q2 LOSS/SHARE $13.92 VS. PROFIT $3.52 YEAR AGO
15.07 15:21dpa-AFX: Vertex Pharma Announces Expanded Approval Of TRIKAFTA By Health Canada
15.07 15:07dpa-AFX: *VERTEX'S TRIKAFTA APPROVED BY HEALTH CANADA FOR CYSTIC FIBROSIS PATIENTS AGED 2+ WITH RARE MUTATIONS
02.07 15:40dpa-AFX: Vertex Pharma: Vanza Triple Granted Priority Review
02.07 15:23dpa-AFX: *VERTEX ANNOUNCES FDA ACCEPTANCE OF NDA FOR TRIPLE COMBINATION TREATMENT FOR CYSTIC FIBROSIS
27.06 08:45dpa-AFX: *REDBURN STARTS VERTEX WITH 'BUY' - PRICE TARGET 554 USD
27.06 08:45dpa-AFX: *REDBURN STARTET VERTEX MIT 'BUY' - ZIEL 554 USD
07.06 14:09dpa-AFX: These Biotech Stocks Hit New Highs, Did You Reap The Rewards?
15.05 16:33dpa-AFX: *VERTEX ELECTS JENNIFER SCHNEIDER AS INDEPENDENT DIRECTOR
06.05 22:13dpa-AFX: Vertex Pharmaceuticals Inc. Q1 Profit Increases, beats estimates
06.05 22:06dpa-AFX: *VERTEX PHARMA Q1 NET PRODUCT REVENUES $2.69 BLN VS. $2.37 BLN LAST YEAR
06.05 22:06dpa-AFX: *VERTEX PHARMA Q1 NET INCOME $1.10 BLN VS. $699.8 MLN PRIOR YEAR
06.05 22:06dpa-AFX: *VERTEX PHARMA Q1 EPS $4.21 VS. $2.69 YEAR AGO
23.04 07:00dpa-AFX: Vertex Pharma Obtains Exclusive License To TreeFrog's Cell Manufacturing Technology, C-Stem
23.04 06:53dpa-AFX: *VERTEX PHARMA OBTAINS EXCLUSIVE LICENSE TO TREEFROG'S PROPRIETARY CELL MANUFACTURING TECHNOLOGY, C-STEM

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH